Skip to main content

Table 1 Base line characteristics of patients included into the RT-qPCR analysis of peripheral blood.

From: Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients

 

Venipuncture

 

A

B

Total number of patients

94

31

Breast cancer

  

   Number

21

31

   Age (yrs)

  

median

54

50

range

35-78

25-75

   Histology

  

IDC

100.0%

64.5%

ILC

0

12.9%

Others/unknown

0

22.6%

   TNM Stage *

  

I

38.1%

3.2%

II

33.3%

48.4%

III

23.8%

19.4%

IV

4.8%

3.2%

Unknown

0

22.6%

Endometrial cancer

  

   Number

25

0

   Age (yrs)

  

median

64

 

range

30-83

 

   Histology

  

Endometrioid

100.0%

 

   FIGO Stage

  

I

60.0%

 

II

8.0%

 

III

28.0%

 

IV

4.0%

 

Cervical Cancer

  

   Number

25

0

   Age (yrs)

  

median

48

 

range

29-78

 

   Histology

  

Non-keratinizing

48.0%

 

Keratinizing

40.0%

 

Others/unknown

12.0%

 

   FIGO Stage

  

I

8.0%

 

II

44.0%

 

III

28.0%

 

IV

20.0%

 

Ovarian cancer

  

   Number

23

0

   Age (yrs)

  

median

53

 

range

37-78

 

   Histology

  

Serous

72.7%

 

Mucinous

12.1%

 

Others/unknown

15.1%

 

   FIGO Stage

  

I

10.0%

 

II

10.0%

 

III

65.0%

 

IV

15.0%

 
  1. Peripheral blood was taken from 94 patients before initial treatment of the primary tumor (A). From 31 recurrent breast cancer patients (B) the blood was taken during disease progression (* TNM stage refers to the primary tumor).
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us